Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2021

Open Access 01-08-2021 | Care | Research Article

Therapeutic optimization through goal-oriented prescription in nursing homes

Authors: N. Molist-Brunet, PhD, D. Sevilla-Sánchez, PhD, J. González-Bueno, V. Garcia-Sánchez, L. A. Segura-Martín, C. Codina-Jané, PhD, J. Espaulella-Panicot, PhD

Published in: International Journal of Clinical Pharmacy | Issue 4/2021

Login to get access

Abstract

Background People living in nursing homes are highly vulnerable and frail. Polypharmacy and inappropriate prescription (IP) are also common problems. Objectives The objectives of the study are (i) to study the baseline situation and calculate the frailty index (FI) of the residents, (ii) to assess the results of routine clinical practice to do a pharmacotherapy review (patient-centred prescription (PCP) model) (Molist Brunet et al., Eur Geriatr Med. 2015;6:565–9) and (iii) to study the relationship between IP and frailty, functional dependence, advanced dementia and end-of-life situation. Setting Two nursing homes in the same geographical area in Catalonia (Spain). Method This was a prospective, descriptive and observational study of elderly nursing home residents. Each patient’s treatment was analysed by applying the PCP model, which centres therapeutic decisions on the patient’s global assessment and individual therapeutic goal. Main outcome measure Prevalence of polypharmacy and IP. Results 103 patients were included. They were characterized by high multimorbidity and frailty. Up to 59.2% were totally dependent. At least one IP was identified in 92.2% of residents. Prior to the pharmacological review, the mean number of chronic medications prescribed per resident was 6.63 (SD 2.93) and after this review it was 4.97 (SD 2.88). Polypharmacy decreased from 72.55% to 52.94% and excessive polypharmacy fell from 18.62% to 5.88%.The highest prevalence of IP was detected in people with a higher FI, in those identified as end-of-life, and also in more highly dependent residents (p < 0.05). Conclusions People who live in nursing homes have an advanced frailty. Establishing individualized therapeutic objectives with the application of the PCP model enabled to detect 92.2% of IP. People who are frailer, are functionally more dependent and those who are end-of-life are prescribed with inappropriate medication more frequently.
Literature
1.
go back to reference Burns E, Nair S. New horizons in care home medicine. Age Ageing. 2014;43:2–7.CrossRef Burns E, Nair S. New horizons in care home medicine. Age Ageing. 2014;43:2–7.CrossRef
2.
go back to reference Bowman C, Whistler J, Ellerby M. A national census of care home residents. Age Ageing. 2004;33:561–6.CrossRef Bowman C, Whistler J, Ellerby M. A national census of care home residents. Age Ageing. 2004;33:561–6.CrossRef
3.
go back to reference Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: an emerging research and clinical paradigm—issues and controversies. J Gerontol A Biol Sci Med Sci. 2009;62:731–7.CrossRef Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, et al. Frailty: an emerging research and clinical paradigm—issues and controversies. J Gerontol A Biol Sci Med Sci. 2009;62:731–7.CrossRef
4.
go back to reference Gordon AL, Logan PA, Jones RG, Forrester-Paton C, Mamo JP, Gladman JR. A systematic mapping review of Randomized Controlled Trials (RCTs) in care homes. BMC Geriatr. 2012;12:31.CrossRef Gordon AL, Logan PA, Jones RG, Forrester-Paton C, Mamo JP, Gladman JR. A systematic mapping review of Randomized Controlled Trials (RCTs) in care homes. BMC Geriatr. 2012;12:31.CrossRef
5.
go back to reference Gordon AL, Franklin M, Bradshaw L, Logan P, Elliott R, Gladman JRF. Health status of UK care home residents: a cohort study. Age Ageing. 2014;43:97–103.CrossRef Gordon AL, Franklin M, Bradshaw L, Logan P, Elliott R, Gladman JRF. Health status of UK care home residents: a cohort study. Age Ageing. 2014;43:97–103.CrossRef
6.
go back to reference Santaeugènia S, Ruíz R, Amblàs-Novellas J. Bases conceptuals i model d’atenció per a les persones fràgils, amb cronicitat complexa (PCC) o avançada (MACA). Programa de prevenció i atenció a la cronicitat. Pla director sociosanitari. Direcció estratègica d’atenció primària. 2020. Santaeugènia S, Ruíz R, Amblàs-Novellas J. Bases conceptuals i model d’atenció per a les persones fràgils, amb cronicitat complexa (PCC) o avançada (MACA). Programa de prevenció i atenció a la cronicitat. Pla director sociosanitari. Direcció estratègica d’atenció primària. 2020.
7.
go back to reference Uriz F, Arizcuren MA, Burguete Y, Leache L, Arizcuren A, Malafarina V. Variables asociadas a polifarmacia y prescripción inadecuada en el medio residencial geriátrico. Rev Esp Geriatr Gerontol. 2018;53:111.CrossRef Uriz F, Arizcuren MA, Burguete Y, Leache L, Arizcuren A, Malafarina V. Variables asociadas a polifarmacia y prescripción inadecuada en el medio residencial geriátrico. Rev Esp Geriatr Gerontol. 2018;53:111.CrossRef
8.
go back to reference Morley JE. Inappropriate drug prescribing and polypharmacy are major causes of poor outcomes in long-term care. J Am Med Dir Assoc. 2014;15:780–2.CrossRef Morley JE. Inappropriate drug prescribing and polypharmacy are major causes of poor outcomes in long-term care. J Am Med Dir Assoc. 2014;15:780–2.CrossRef
9.
go back to reference Little MO, Morley A. Reducing polypharmacy: evidence from a simple quality improvement initiative. J Am Med Dir Assoc. 2013;14:152–6.CrossRef Little MO, Morley A. Reducing polypharmacy: evidence from a simple quality improvement initiative. J Am Med Dir Assoc. 2013;14:152–6.CrossRef
10.
go back to reference Hughes LD, McMurdo MET, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42:62–9.CrossRef Hughes LD, McMurdo MET, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42:62–9.CrossRef
11.
go back to reference Sanford A, Morley JE. Are the new guidelines for cholesterol and hypertension age friendly? J Am Med Dir Assoc. 2014;15:373–5.CrossRef Sanford A, Morley JE. Are the new guidelines for cholesterol and hypertension age friendly? J Am Med Dir Assoc. 2014;15:373–5.CrossRef
12.
go back to reference Welsh T, Gladman J, Gordon AL. The treatment of hypertension in care home residents: a systematic review of observational studies. J Am Med Dir Assoc. 2014;15:8–16.CrossRef Welsh T, Gladman J, Gordon AL. The treatment of hypertension in care home residents: a systematic review of observational studies. J Am Med Dir Assoc. 2014;15:8–16.CrossRef
13.
go back to reference Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33:549–57.CrossRef Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33:549–57.CrossRef
14.
go back to reference Kua C-H, Mak VSL, Huey Lee SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20:362–372. e11. Kua C-H, Mak VSL, Huey Lee SW. Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis. J Am Med Dir Assoc. 2019;20:362–372. e11.
15.
go back to reference Generalitat de Catalunya. Departament de Salut. El procés assistencial d’atenció a la cronicitat i la complexitat a la xarxa d’atenció primària. 2019. Generalitat de Catalunya. Departament de Salut. El procés assistencial d’atenció a la cronicitat i la complexitat a la xarxa d’atenció primària. 2019.
16.
go back to reference Molist Brunet N, Espaulella Panicot J, Sevilla-Sánchez D, Amblàs Novellas J, Codina Jané C, Altimiras Roset J, et al. A patient-centered prescription model assessing the appropriateness of chronic drug therapy in older patients at the end of life. Eur Geriatr Med. 2015;6:565–9.CrossRef Molist Brunet N, Espaulella Panicot J, Sevilla-Sánchez D, Amblàs Novellas J, Codina Jané C, Altimiras Roset J, et al. A patient-centered prescription model assessing the appropriateness of chronic drug therapy in older patients at the end of life. Eur Geriatr Med. 2015;6:565–9.CrossRef
17.
go back to reference Lee SJ, Kim CM. Individualizing prevention for older adults. J Am Geriatr Soc. 2018;66:229–34.CrossRef Lee SJ, Kim CM. Individualizing prevention for older adults. J Am Geriatr Soc. 2018;66:229–34.CrossRef
18.
go back to reference O’Mahony D, O’Connor MN. Pharmacotherapy at the end-of-life. Age Ageing. 2011;40:419–22.CrossRef O’Mahony D, O’Connor MN. Pharmacotherapy at the end-of-life. Age Ageing. 2011;40:419–22.CrossRef
19.
go back to reference Gómez-Batiste X, Martínez-Muñoz M, Blay C, Amblàs J, Vila L, Costa X, et al. Prevalence and characteristics of patients with advanced chronic conditions in need of palliative care in the general population: a cross-sectional study. Palliat Med. 2014;28:302–11.CrossRef Gómez-Batiste X, Martínez-Muñoz M, Blay C, Amblàs J, Vila L, Costa X, et al. Prevalence and characteristics of patients with advanced chronic conditions in need of palliative care in the general population: a cross-sectional study. Palliat Med. 2014;28:302–11.CrossRef
20.
go back to reference Sue Kirkman M, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60:2342–56.CrossRef Sue Kirkman M, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults: a consensus report. J Am Geriatr Soc. 2012;60:2342–56.CrossRef
21.
go back to reference Gómez-Huelgas R, Gómez Peralta F, Rodríguez Mañas L, Formiga F, Puig Domingo M, Mediavilla Bravo JJ, et al. Treatment of type 2 diabetes mellitus in elderly patients. Rev Clínica Española (English Ed.). 2018;218:74–88. Gómez-Huelgas R, Gómez Peralta F, Rodríguez Mañas L, Formiga F, Puig Domingo M, Mediavilla Bravo JJ, et al. Treatment of type 2 diabetes mellitus in elderly patients. Rev Clínica Española (English Ed.). 2018;218:74–88.
22.
go back to reference Hambling CE, Khunti K, Cos X, Wens J, Martinez L, Topsever P, et al. Factors influencing safe glucose-lowering in older adults with type 2 diabetes: a PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people. Prim Care Diabetes. 2019;13:330–52.CrossRef Hambling CE, Khunti K, Cos X, Wens J, Martinez L, Topsever P, et al. Factors influencing safe glucose-lowering in older adults with type 2 diabetes: a PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people. Prim Care Diabetes. 2019;13:330–52.CrossRef
23.
go back to reference O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44:213–8.CrossRef O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44:213–8.CrossRef
24.
go back to reference Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, et al. Practical approach to initiating SGLT2 inhibitors in Type 2 diabetes. Diabetes Ther. 2017;8:953–62.CrossRef Gomez-Peralta F, Abreu C, Lecube A, Bellido D, Soto A, Morales C, et al. Practical approach to initiating SGLT2 inhibitors in Type 2 diabetes. Diabetes Ther. 2017;8:953–62.CrossRef
25.
go back to reference National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. 2016. National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. 2016.
26.
go back to reference Boockvar KS, Song W, Lee S, Intrator O. Hypertension treatment in US long-term nursing home residents with and without dementia. J Am Geriatr Soc. 2019;67:1–7.CrossRef Boockvar KS, Song W, Lee S, Intrator O. Hypertension treatment in US long-term nursing home residents with and without dementia. J Am Geriatr Soc. 2019;67:1–7.CrossRef
27.
go back to reference Onder G, Vetrano DL, Marengoni A, Bell JS, Johnell K, Palmer K. Accounting for frailty when treating chronic diseases. Eur J Intern Med. 2018;56:49–52.CrossRef Onder G, Vetrano DL, Marengoni A, Bell JS, Johnell K, Palmer K. Accounting for frailty when treating chronic diseases. Eur J Intern Med. 2018;56:49–52.CrossRef
28.
go back to reference Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing. 2010;39:674–80.CrossRef Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing. 2010;39:674–80.CrossRef
29.
go back to reference van der Steen JT, Radbruch L, Hertogh CMPM, de Boer ME, Hughes JC, Larkin P, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med. 2014;28:197–209.CrossRef van der Steen JT, Radbruch L, Hertogh CMPM, de Boer ME, Hughes JC, Larkin P, et al. White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med. 2014;28:197–209.CrossRef
30.
go back to reference Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018;64:17–27.PubMedPubMedCentral Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018;64:17–27.PubMedPubMedCentral
31.
go back to reference Lavan AH, Gallagher P, Parsons C, O’Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46:600–7.CrossRef Lavan AH, Gallagher P, Parsons C, O’Mahony D. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing. 2017;46:600–7.CrossRef
32.
go back to reference Gokula M, Holmes HM. Tools to reduce polypharmacy. Clin Geriatr Med. 2012;28:323–41.CrossRef Gokula M, Holmes HM. Tools to reduce polypharmacy. Clin Geriatr Med. 2012;28:323–41.CrossRef
33.
go back to reference Granger CV, Albretch GLH. Outcome of comprehensive medical rehabilitation: measurement by PULSES profile and the Barthel index. Arch Phys Med Rehabil. 1979;60:145–54.PubMed Granger CV, Albretch GLH. Outcome of comprehensive medical rehabilitation: measurement by PULSES profile and the Barthel index. Arch Phys Med Rehabil. 1979;60:145–54.PubMed
34.
go back to reference Reisberg B, Ferris S, De Leon M, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136–9.CrossRef Reisberg B, Ferris S, De Leon M, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136–9.CrossRef
35.
go back to reference Woolf C, Slavin MJ, Draper B, Thomassen F, Kochan NA, Reppermund S, et al. Can the clinical dementia rating Scale identify mild cognitive impairment and predict cognitive and functional decline? Dement Geriatr Cogn Disord. 2016;41:292–302.CrossRef Woolf C, Slavin MJ, Draper B, Thomassen F, Kochan NA, Reppermund S, et al. Can the clinical dementia rating Scale identify mild cognitive impairment and predict cognitive and functional decline? Dement Geriatr Cogn Disord. 2016;41:292–302.CrossRef
36.
go back to reference Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989–95.CrossRef Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65:989–95.CrossRef
37.
go back to reference Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002–12.CrossRef Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002–12.CrossRef
38.
go back to reference Sevilla-Sanchez D, Molist-Brunet N, Amblàs-Novellas J, Roura-Poch P, Espaulella-Panicot J, Codina-Jané C. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission. Eur J Clin Pharmacol. 2017;73:79–89.CrossRef Sevilla-Sanchez D, Molist-Brunet N, Amblàs-Novellas J, Roura-Poch P, Espaulella-Panicot J, Codina-Jané C. Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission. Eur J Clin Pharmacol. 2017;73:79–89.CrossRef
39.
go back to reference Amblàs-Novellas J, Martori JC, Molist-Brunet N, Oller R, Gómez-Batiste X. Frail-VIG index: design and evaluation of a new frailty index based on the comprehensive geriatric assessment. Rev Esp Geriatr Gerontol. 2016;52:119–27.CrossRef Amblàs-Novellas J, Martori JC, Molist-Brunet N, Oller R, Gómez-Batiste X. Frail-VIG index: design and evaluation of a new frailty index based on the comprehensive geriatric assessment. Rev Esp Geriatr Gerontol. 2016;52:119–27.CrossRef
40.
go back to reference Amblàs-Novellas J, Martori JC, Espaulella J, Oller R, Molist-Brunet N, Inzitari M, et al. Frail-VIG index: a concise frailty evaluation tool for rapid geriatric assessment. BMC Geriatr. 2018;18:29.CrossRef Amblàs-Novellas J, Martori JC, Espaulella J, Oller R, Molist-Brunet N, Inzitari M, et al. Frail-VIG index: a concise frailty evaluation tool for rapid geriatric assessment. BMC Geriatr. 2018;18:29.CrossRef
41.
go back to reference Boyd K, Murray SA. Recognising and managing key transitions in end of life care. BMJ. 2010;341:c4863.CrossRef Boyd K, Murray SA. Recognising and managing key transitions in end of life care. BMJ. 2010;341:c4863.CrossRef
42.
go back to reference Merel SE, Paauw DS. Common drug side effects and drug-drug interactions in elderly adults in primary care. J Am Geriatr Soc. 2017;65:1578–85.CrossRef Merel SE, Paauw DS. Common drug side effects and drug-drug interactions in elderly adults in primary care. J Am Geriatr Soc. 2017;65:1578–85.CrossRef
43.
go back to reference Roe B, Flanagan L, Jack B, Barrett J, Chung A, Shaw C, et al. Systematic review of the management of incontinence and promotion of continence in older people in care homes: descriptive studies with urinary incontinence as primary focus. J Adv Nurs. 2011;67:228–50.CrossRef Roe B, Flanagan L, Jack B, Barrett J, Chung A, Shaw C, et al. Systematic review of the management of incontinence and promotion of continence in older people in care homes: descriptive studies with urinary incontinence as primary focus. J Adv Nurs. 2011;67:228–50.CrossRef
44.
go back to reference Harris T, Carey IM, Shah SM, DeWilde S, Cook DG. Antidepressant prescribing in older primary care patients in community and care home settings in England and Wales. J Am Med Dir Assoc. 2012;13:41–7.CrossRef Harris T, Carey IM, Shah SM, DeWilde S, Cook DG. Antidepressant prescribing in older primary care patients in community and care home settings in England and Wales. J Am Med Dir Assoc. 2012;13:41–7.CrossRef
45.
go back to reference van Marwijk H, Spiegel W. Overuse of antipsychotic medication in elderly people with dementia? A view from general practice. Ment Health Fam Med. 2009;6:191–3.PubMedPubMedCentral van Marwijk H, Spiegel W. Overuse of antipsychotic medication in elderly people with dementia? A view from general practice. Ment Health Fam Med. 2009;6:191–3.PubMedPubMedCentral
Metadata
Title
Therapeutic optimization through goal-oriented prescription in nursing homes
Authors
N. Molist-Brunet, PhD
D. Sevilla-Sánchez, PhD
J. González-Bueno
V. Garcia-Sánchez
L. A. Segura-Martín
C. Codina-Jané, PhD
J. Espaulella-Panicot, PhD
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 4/2021
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-01206-x

Other articles of this Issue 4/2021

International Journal of Clinical Pharmacy 4/2021 Go to the issue